Matthew Coward
Papers
2
Total Citations
8
H-Index
2
About
Matthew Coward is a urologic surgeon and researcher whose work centers on advancing surgical treatments for bladder cancer, with a particular focus on robotic-assisted techniques. His major contributions include pivotal studies comparing open versus robotic-assisted laparoscopic radical cystectomy, a complex procedure for muscle-invasive bladder cancer. In his 2009 prospective randomized trial, Coward and colleagues provided interim results demonstrating that robotic-assisted surgery offers comparable oncologic outcomes to open surgery, while potentially reducing perioperative morbidity. This work, alongside his analysis of perioperative outcomes in 85 patients undergoing robotic cystectomy, helped establish the feasibility and safety of minimally invasive approaches in urologic oncology. Though early in his career, these studies have garnered citations from peers validating their impact on surgical practice. Coward’s research directly addresses the critical question of how to optimize recovery without compromising cancer control, making him a notable voice in the evolution of robotic urologic surgery. His ongoing work continues to shape evidence-based guidelines for bladder cancer management.
Research Focus
Key Achievements
Top Papers
- 1
- 2